Zydus launches VaxiFluTM trivalent influenza vaccine for flu protection in India

Zydus Lifesciences has introduced VaxiFlu, a trivalent influenza vaccine, in India. This vaccine aligns with WHO guidelines. It is for individuals aged six months and above. The vaccine contains updated strains for optimal protection. Flu remains a global health concern. It causes millions of severe illnesses and respiratory deaths annually. VaxiFlu aims to reduce vaccine-preventable diseases, especially in high-risk groups.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/HVIgytb
via IFTTT